Cargando…

Coronavirus disease 2019 vaccines: challenges of using global mass vaccination to achieve herd immunity

Detalles Bibliográficos
Autores principales:	Bao, Pengtao, Gong, Jiuyu, Mu, Mi, Que, Yifan, Hu, Peng, Luo, Jiang, Chang, Christopher, Xu, Guogang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325752/ https://www.ncbi.nlm.nih.gov/pubmed/36806245 http://dx.doi.org/10.1097/CM9.0000000000002270

Ejemplares similares

Split-dosing of coronavirus disease 2019 vaccines
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Immune response after vaccination using inactivated vaccine for coronavirus disease 2019
por: Sun, Ya, et al.
Publicado: (2023)

Aseptic Meningitis and mRNA Coronavirus Disease 2019 Vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Mandatory vaccination in child daycare and its relevance to coronavirus disease 2019
por: den Exter, André
Publicado: (2021)

Reply: Aseptic Meningitis and mRNA Coronavirus Disease 2019 Vaccine
por: Heo, Sang Taek
Publicado: (2022)

Coronavirus disease 2019 vaccine for children in China: when to start? Mandatory or voluntary?
por: Liu, Fei, et al.
Publicado: (2021)

Coronavirus disease 2019 (COVID‐19) vaccination in patients with cirrhosis: Does it work?
por: Calleri, Alberto, et al.
Publicado: (2022)

Clinical Considerations During Breakthrough Coronavirus Disease 2019 Infections in Vaccinated Individuals With Autoimmunity
por: Rocco, Joseph M, et al.
Publicado: (2021)

Immune parameters during anaphylaxis to messenger RNA coronavirus disease 2019 vaccines: Not the usual suspects?
por: de Chaisemartin, Luc, et al.
Publicado: (2022)

Antibody response to coronavirus disease 2019 vaccines after allergic reaction to first dose: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Antibody Response to the Coronavirus Disease 2019 Ad26.COV2.S Vaccine Among Maintenance Dialysis Patients
por: Ficociello, Linda H., et al.
Publicado: (2022)

Bacillus Calmette-Guerin (BCG) Site Reaction after Coronavirus Disease 2019 (COVID-19) mRNA Vaccination
por: Günaydın, Sibel Doğan, et al.
Publicado: (2023)

Achieving the end game: employing “vaccine diplomacy” to eradicate polio in Pakistan
por: Shakeel, Shahella Idrees, et al.
Publicado: (2019)

Herd immunity confusion
por: Medley, Graham F
Publicado: (2020)

Protecting the Herd: Why Pharmacists Matter in Mass Vaccination
por: Lee, Lois, et al.
Publicado: (2020)

COVID-19 Vaccine Superstations as a Model to Rapidly Achieve Herd Immunity
por: Keehner, Jocelyn, et al.
Publicado: (2021)

Global COVID-19 vaccine roll-out: time to randomise vaccine allocation?
por: Watson, Samuel I, et al.
Publicado: (2021)

The historic success of vaccination and the global challenge posed by inaccurate knowledge in social networks
Publicado: (2021)

Epitopes for a 2019-nCoV vaccine
por: Lucchese, Guglielmo
Publicado: (2020)

Does the homologous booster with the inactivated coronavirus disease 2019 vaccine work for the omicron variant? Real-world evidence from Jilin, China
por: Guo, Jun, et al.
Publicado: (2023)

Vaccine herd effect
por: Kim, Tae Hyong, et al.
Publicado: (2011)

A global compact to counter vaccine nationalism
por: Jha, Prabhat, et al.
Publicado: (2021)

Famotidine and Coronavirus Disease 2019
por: Freedberg, Daniel E., et al.
Publicado: (2021)

Human Challenge Studies Are Unlikely to Accelerate Coronavirus Vaccine Licensure Due to Ethical and Practical Issues
por: Spinola, Stanley M, et al.
Publicado: (2020)

Vaccination Coverage for Routine Vaccines and Herd Immunity Levels against Measles and Pertussis in the World in 2019
por: Plans-Rubió, Pedro
Publicado: (2021)

Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.
por: Gumel, Abba B., et al.
Publicado: (2021)

Effectiveness of the CoronaVac® vaccine in a region of the Colombian Amazon, was herd immunity achieved?
por: Serrano-Coll, Héctor, et al.
Publicado: (2022)

Vaccine Hesitancy Is a Barrier to Achieving Equitable Herd Immunity Among Racial Minorities
por: Gerretsen, Philip, et al.
Publicado: (2021)

Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination
por: Anderson, Roy M, et al.
Publicado: (2020)

Famotidine and Mortality in Coronavirus Disease 2019
por: Sethia, Rahul, et al.
Publicado: (2021)

Asthma and prognosis of coronavirus disease 2019
por: Özdemir, Öner
Publicado: (2022)

To halt the spread of imported coronavirus disease 2019 cases in China: Action and challenges
por: Fu, Jiye, et al.
Publicado: (2021)

Mpox vaccination in global perspective: priorities and challenges
por: Rana, Jigyasa, et al.
Publicado: (2023)

The Pathogenesis of Eosinophilic Asthma: A Positive Feedback Mechanism That Promotes Th2 Immune Response via Filaggrin Deficiency
por: Gao, Wei, et al.
Publicado: (2021)

Coronavirus disease 2019 vaccines: landscape of global studies and potential risks
por: Jiang, Hu-Da-Chuan, et al.
Publicado: (2021)

A step backwards in the fight against global vaccine inequities
por: Aryeetey, Ernest, et al.
Publicado: (2021)

COVID-19 booster doses in pregnancy and global vaccine equity
por: Kalafat, Erkan, et al.
Publicado: (2022)

MicroCLOTS pathophysiology in coronavirus disease 2019
por: Renzi, Samuele, et al.
Publicado: (2023)

Vaccination Did Not Prevent Severe Coronavirus Disease 2019 in an Outbreak Among Older Residents of a Nursing Home, B.1.617.2 Variant, July 2021( )
por: Buskermolen, Maaike, et al.
Publicado: (2022)

A letter to the editor on “World Health Organization declares global emergency: A review of the 2019 novel Coronavirus (COVID-19)”
por: Pérez-Campos Mayoral, Laura, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0k251atpqgaulehdmhgv7hrjmj